Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Rheumatoid arthritis (RA) is a chronic progressive autoimmune disease with predominantly joint involvement. To compare the efficacy and difference between elamod and tofacitib in the treatment of rheumatoid factor-positive and negative rheumatoid arthritis in RA patients with poor outcome after csDMARDs dosing, in order to better inform the clinical management.
Epistemonikos ID: 9859b796f184f5b922d19b3cd3e42792dedbdb40
First added on: May 15, 2024